Search results
Showing 3301 to 3350 of 8238 results
Early value assessment (EVA) guidance on artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway.
Early value assessment (EVA) guidance on point-of-care tests for urinary tract infections to improve antimicrobial prescribing.
Early value assessment (EVA) guidance on the Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies.
Early value assessment (EVA) guidance on the ProKnow cloud-based system for radiotherapy data storage, communication and management.
Early value assessment (EVA) guidance on digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments.
Faecal microbiota transplant for recurrent Clostridioides difficile infection (HTG638)
Evidence-based recommendations on faecal microbiota transplant for recurrent Clostridioides difficile infection.
GreenLight XPS for treating benign prostatic hyperplasia (HTG650)
Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia.
Home News In-depth {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"
Read NICE's statement on modern slavery and human trafficking.
Home About us...
The time and proportion of pay used by trade union representatives to carry out their union role.
Home About us Our board Public board meetings...
Information about NICE's gender pay gap data for the 12 months leading up to 31 March 2025.
Outside interests of the NICE board
Home About us Our board Public board meetings...
Home About us Our board Public board meetings...
Agenda and papers of the NICE public board meeting on 17 March 2022
NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.
Details of the business expenses incurred by the board and senior management team in delivery of their duties.
NICE's equality, diversity, and inclusion roadmap and annual action plan - committed to creating a forward-looking, positive work culture where everyone can thrive.
Agenda and papers of the NICE public board meeting on 15 May 2024
Agenda and papers of the NICE public board meeting on 17 May 2023
Agenda and papers of the NICE public board meeting on 25 May 2022
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence.
Our board has 2 sub-committees: the audit and risk assurance committee and the remuneration committee.
Agenda and papers of the NICE public board meeting on 17 July 2024
Agenda and papers of the NICE public board meeting on 19 July 2023
Agenda and papers of the NICE public board meeting on 22 July
Home About us Our board Public board meetings...
Agenda and papers of the NICE public board meeting on 25 September 2024
Agenda and papers of the NICE public board meeting on 21 September 2023
Agenda and papers of the NICE public board meeting on 22 September
IMI and H2020 Grant funded projects with NICE
Resources to help with NHS access, system engagement and understanding the therapeutic landscape.
We have a library of over 200 quality standards and a single menu of indicators, designed to help define and measure quality in health, public health and social care.
We provide an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care.
Home What NICE does {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Our science policy and research programme team produces high-quality, impactful research.
NICE's partners
Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care
Our guidance is developed by independent committees, including professionals and lay members, and consulted on by stakeholders.
NICE's past research and projects
Information and benefits about shared decision making. Includes links to patient decision aids.
Home What NICE does Life sciences: how to get your product to market NICE Advice service {"@context":"http://schema.org","@type":"BreadcrumbList"
International collaboration with NICE
NICE Advice - a fee-based advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market,
Science policy projects with NICE.
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Our projects and partnerships help us anticipate and adapt to policy developments, including changes in health and social care delivery.